Why an Amyloidosis Network?

An amyloidosis network like BE.Amycon offers numerous advantages:

BE.Amycon's comprehensive approach and collaborative structure aims to change and upgrade amyloidosis care in Belgium and beyond. We aim to position BE.Amycon as a pioneering force in the field of rare disease research and treatment.

BE.Amycon Amyloidosis Network: Specialized Care, Research & Innovation, Integrated Expertise & Centralized Resources

 

Specialized Care

BE.Amycon ensures tailored care by bringing together specialists from diverse disciplines like hematology, neurology, cardiology, and nephrology. This collaboration ensures comprehensive and multifaceted approaches to patient care.

With its Patient-Centric focus BE.Amycon prioritizes patient's needs. We strive to offer access to state-of-the-art treatments, clinical trials, and support groups. Patients will benefit from standardized care, early detection, and improved treatment outcomes.
 

Integrated Expertise

The network acts as a hub for sharing knowledge and expertise among researchers and clinicians. This collaboration fosters the development of cutting-edge diagnostic tools, treatments, and therapies for various forms of amyloidosis.
 

The network will design guidelines and educational programs aimed at healthcare professionals, raising awareness about amyloidosis symptoms, diagnosis, and treatment. This initiative empowers clinicians to identify the disease early, leading to timely interventions.
 

Research and Innovation

The network serves as a platform for innovative research initiatives, paving the way for the development of novel diagnostic tests, therapeutic approaches, and potential cures. The collaboration among various stakeholders encourages the translation of research findings into practical applications for patients.
 

BE.Amycon's collaborations extend beyond Belgium, fostering partnerships with global experts, institutions, and organizations. This global network enhances knowledge exchange, ensuring access to the latest advancements and best practices in amyloidosis care.
 

Centralized Resources

By centralizing diagnostic procedures, databases, and research efforts, BE.Amycon streamlines the process for both patients and healthcare providers. This centralized approach ensures consistency and accuracy in diagnosis and treatment across different medical institutions.

This approach will also allow us to better support and advocate for our patients. We will support patients, families, and caregivers by facilitating timely access to information, resources, and we will strive to offer emotional support through specilised care.